These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 30370535)
1. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma. Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535 [TBL] [Abstract][Full Text] [Related]
2. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
3. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
5. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression. Li H; Tong L; Tao H; Liu Z Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203 [TBL] [Abstract][Full Text] [Related]
6. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162 [TBL] [Abstract][Full Text] [Related]
7. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma. Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500 [TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma. Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma. Su Y; Shetty A; Jiang F Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma. Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197 [TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis. He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535 [TBL] [Abstract][Full Text] [Related]
13. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis. Hou J; Yao C Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215 [TBL] [Abstract][Full Text] [Related]
14. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma. Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267 [TBL] [Abstract][Full Text] [Related]
15. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data. Yang Z; Yin H; Shi L; Qian X Int J Mol Med; 2020 May; 45(5):1397-1408. PubMed ID: 32323746 [TBL] [Abstract][Full Text] [Related]
16. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis. Wang W; He J; Lu H; Kong Q; Lin S Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
18. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma. Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256 [TBL] [Abstract][Full Text] [Related]
19. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas. Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966 [TBL] [Abstract][Full Text] [Related]
20. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma. Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]